# Repeated Neurocognitive Measurements in Depressed Patients

> **NCT04916548** · PHASE1,PHASE2 · COMPLETED · sponsor: **Rebecca Price** · enrollment: 15 (actual)

## Conditions studied

- Depression, Unipolar

## Interventions

- **DRUG:** Intravenous Ketamine

## Key facts

- **NCT ID:** NCT04916548
- **Lead sponsor:** Rebecca Price
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-16
- **Primary completion:** 2023-07-15
- **Final completion:** 2023-08-15
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2024-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04916548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04916548, "Repeated Neurocognitive Measurements in Depressed Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04916548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*